US sues KKR for allegedly avoiding antitrust scrutiny
WASHINGTON (Reuters) -The U.S. filed a civil lawsuit on Tuesday against private equity firm KKR & Co (NYSE:KKR), “for repeatedly flouting the premerger antitrust review process,” alleging the company avoided antitrust scrutiny for at least 16 deals from 2021 to
European shares little changed amid threats of rising yields and tariffs
By Nikhil Sharma and Pranav Kashyap (Reuters) – European shares wrapped up Tuesday little changed as the pressure from rising yields continued to weigh on regional equities, while looming threat of tariffs from U.S. President-elect Donald Trump kept investors on edge. The
Morgan Stanley cuts Chegg stock to underweight amid pressures from AI
Investing.com — Morgan Stanley downgraded Chegg Inc (NYSE:CHGG) to “Underweight” on deteriorating third-party data trends and a challenging competitive environment. The brokerage set a price target of $1.25, reflecting concerns about declining revenue and margins. Web traffic and app downloads weakened
Wall St slips as focus shifts to earnings, consumer inflation data
By Johann M Cherian and Sukriti Gupta (Reuters) -Wall Street’s main indexes fell on Tuesday as investors turned their attention to upcoming inflation data and quarterly earnings reports, which are expected to provide insights into the health of the U.S. economy. Stocks
Pfizer to sell 7.7% stake in Haleon for potential $3.1 billion, Bloomberg reports
Investing.com — Pfizer Inc. (NYSE:PFE) is planning a significant share sale in Haleon Plc, the company known for making Sensodyne toothpaste, Bloomberg reported on Tuesday. The pharmaceutical giant is offering approximately 700 million shares, which amounts to a 7.7%